PRIMARY CNS LYMPHOMA (PCNSL)
Clinical trials for PRIMARY CNS LYMPHOMA (PCNSL) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CNS LYMPHOMA (PCNSL) trials appear
Sign up with your email to follow new studies for PRIMARY CNS LYMPHOMA (PCNSL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat brain cancer: combo therapy enters trial
Disease control Recruiting nowThis study tests a new drug called epcoritamab, given with two other drugs (lenalidomide and rituximab), for people whose primary CNS lymphoma has returned or stopped responding to treatment. The goal is to see if this combination can shrink or control the cancer. About 60 adults…
Matched conditions: PRIMARY CNS LYMPHOMA (PCNSL)
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental CAR-T therapy targets Hard-to-Treat brain cancer
Disease control Recruiting nowThis pilot study is testing a new treatment called Anbal-cel for people with relapsed or refractory primary or secondary central nervous system lymphoma. Anbal-cel is a CAR-T cell therapy made from the patient's own immune cells. The study will enroll 12 participants to see if th…
Matched conditions: PRIMARY CNS LYMPHOMA (PCNSL)
Phase: PHASE2 • Sponsor: Hyungwoo Cho • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC